BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11388032)

  • 1. [Idiopathic hypereosinophilic syndrome: from the clinic to the laboratory, from the laboratory to the clinic].
    Roufosse F; Cogan E
    Rev Med Brux; 2001 Apr; 22(2):A113-5. PubMed ID: 11388032
    [No Abstract]   [Full Text] [Related]  

  • 2. [Th2 lymphocytes in man: a new cause of hypereosinophilic syndrome].
    Goldman M
    Bull Mem Acad R Med Belg; 2000; 155(1-2):141-5; discussion 145-6. PubMed ID: 11048401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypereosinophilic syndrome revisited.
    Roufosse F; Cogan E; Goldman M
    Annu Rev Med; 2003; 54():169-84. PubMed ID: 12525672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome.
    Roufosse F; Simonart T; Cogan E
    Br J Dermatol; 2001 Mar; 144(3):639. PubMed ID: 11260039
    [No Abstract]   [Full Text] [Related]  

  • 5. The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES).
    Helbig G; Wichary R; Razny M; Rodzaj M; Wozniczka K; Dziaczkowska-Suszek J; Kyrcz-Krzemien S
    Scand J Immunol; 2010 Oct; 72(4):372-3. PubMed ID: 20883323
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinophilia--idiopathic or not?
    Bain BJ
    N Engl J Med; 1999 Oct; 341(15):1141-3. PubMed ID: 10511615
    [No Abstract]   [Full Text] [Related]  

  • 7. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes.
    Bank I; Amariglio N; Reshef A; Hardan I; Confino Y; Trau H; Shtrasburg S; Langevitz P; Monselise Y; Shalit M; Rechavi G
    Leuk Lymphoma; 2001 Jun; 42(1-2):123-33. PubMed ID: 11699199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome.
    Willard-Gallo KE; Badran BM; Ravoet M; Zerghe A; Burny A; Martiat P; Goldman M; Roufosse F; Sibille C
    Exp Hematol; 2005 Oct; 33(10):1147-59. PubMed ID: 16219537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypereosinophilia with abnormal T cells, trisomy 7 and elevated TARC serum level.
    Roumier AS; Grardel N; Laï JL; Becqueriaux I; Ghomari K; de Lavareille A; Roufosse F; Prin L; Capron M
    Haematologica; 2003 Jul; 88(7):ECR24. PubMed ID: 12857571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome.
    Roufosse F; Schandené L; Sibille C; Willard-Gallo K; Kennes B; Efira A; Goldman M; Cogan E
    Br J Haematol; 2000 Jun; 109(3):540-8. PubMed ID: 10886202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic evaluation of circulating T-cell clones in hypereosinophilic syndromes with or without abnormal CD3 and CD4 lymphocytes.
    Bassan R; Locatelli G; Borleri G; Salvi A; Barbui T
    Haematologica; 2004 Feb; 89(2):238-9. PubMed ID: 15003902
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric hypereosinophilic syndrome (HES) clinically differs from adult HES, but there is a lack of confirmatory laboratory data.
    Yildiran A; Ikincioğullari A
    J Pediatr; 2005 Dec; 147(6):869; author reply 869-70. PubMed ID: 16356454
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic hypereosinophilic syndromes: when autoimmunity is Th2 mediated.
    Matucci A; Nencini F; Maggi E; Vultaggio A
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):175-180. PubMed ID: 31985544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypereosinophilic syndrome with elevated serum tryptase versus systemic mast cell disease associated with eosinophilia: 2 distinct entities?
    Tefferi A; Pardanani A; Li CY
    Blood; 2003 Oct; 102(8):3073-4; author reply 3074. PubMed ID: 14527892
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypereosinophilic asthma].
    Cordier JF
    Rev Prat; 2006 Feb; 56(4):353-8. PubMed ID: 16629078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of idiopathic hypereosinophilic syndrome with hepatic involvement in a 5-year-old boy].
    Kim YM; Lee YJ; Park JH; Lee JW; Lee CH
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):321-6. PubMed ID: 12499791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic variant hypereosinophilic syndromes.
    Roufosse F; Cogan E; Goldman M
    Immunol Allergy Clin North Am; 2007 Aug; 27(3):389-413. PubMed ID: 17868856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-refractory idiopathic hypereosinophilic syndrome: pitfalls and progress with use of novel drugs.
    Bleeker JS; Syed FF; Cooper LT; Weiler CR; Tefferi A; Pardanani A
    Am J Hematol; 2012 Jul; 87(7):703-6. PubMed ID: 22367886
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional lymphocyte subset assessment of the Th1/Th2 profile in patients with autoimmune thyroiditis by flowcytometric analysis of peripheral lymphocytes.
    Colin IM; Isaac J; Dupret P; Ledant T; D'Hautcourt JL
    J Biol Regul Homeost Agents; 2004; 18(1):72-6. PubMed ID: 15323363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th2-type cytokines, hypereosinophilia, and interleukin-5 in HIV disease.
    Paganelli R; Scala E; Mazzone AM; Rosso R; Mattiacci G; Dell'Anna L; Mezzaroma I; Aiuti F
    Allergy; 1997 Jan; 52(1):110-1. PubMed ID: 9062639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.